Additionally, apart from mutations, AR copy number variation and spliceosome variation can also cause ARPI resistance; therefore, focusing solely on AR mutations will have certain limitations in the prognosis analysis of PCa. This evidence concerns the gene AR and posterior cortical atrophy.